Controversies on the values for health instruments of Chinese medicine

Zheng-kun Hou; Xiang Chang; Feng-bin Liu; Nelson Xie; Nicole Guo; Xin-lin Chen

doi:10.1007/s11655-016-2494-1

Your Location：

Home >

Browse articles >

Controversies on the values for health instruments of Chinese medicine

OriginalPaper | Updated：2021-08-27

- Controversies on the values for health instruments of Chinese medicine
- Controversies on the values for health instruments of Chinese medicine
- 中国结合医学杂志（英文版） 2017年23卷第2期页码：146-152
- Affiliations：
  
  1. Gastroenterology Department, First Affiliated Hospital, Guangzhou University of Chinese Medicine,Guangzhou,China
  2. Encephalopathy Department, Xi’an Hospital of Traditional Chinese Medicine,Xi’an,China
  3. Department of Neurosciences, School of Medicine, University of California,San Diego,USA
  4. Department of Preventive Medicine and Health Statistics, School of Medical and Molecular Biosciences, University of Technology Sydney, Ultimo,Australia
  5. Nursing Department, Repatriation General Hospital, Daw Park,Australia
  6. College of Basic Medical Sciences, Guangzhou University of Chinese Medicine,Guangzhou,China
- Author bio：
- Funds：
  
  Supported by the National Natural Science Foundation of China (No. 81303148 and 81373786) and Scientific Research Program of Administrative Bureau of Traditional Chinese Medicine of Guangdong Province, China (No. 20132177)
- DOI：10.1007/s11655-016-2494-1
  中图分类号：
- 纸质出版日期：2017，
  
  网络出版日期：2016-4-4，
Scan for full text
Hou, Zk., Chang, X., Liu, Fb. et al. Controversies on the values for health instruments of Chinese medicine., Chin. J. Integr. Med. 23, 146–152 (2017). https://doi.org/10.1007/s11655-016-2494-1

Zheng-kun Hou, Xiang Chang, Feng-bin Liu, et al. Controversies on the values for health instruments of Chinese medicine[J]. Chinese Journal of Integrative Medicine, 2017,23(2):146-152.
Hou, Zk., Chang, X., Liu, Fb. et al. Controversies on the values for health instruments of Chinese medicine., Chin. J. Integr. Med. 23, 146–152 (2017). https://doi.org/10.1007/s11655-016-2494-1 DOI：

Zheng-kun Hou, Xiang Chang, Feng-bin Liu, et al. Controversies on the values for health instruments of Chinese medicine[J]. Chinese Journal of Integrative Medicine, 2017,23(2):146-152. DOI： 10.1007/s11655-016-2494-1.

摘要

Currently

there are increasing debates on the necessity of health instruments in Chinese medicine (CM) emerging in China. This study aims to reevaluate its status and values. Analyzing the causes

limits

advantages

and properties characters of health instruments in CM

it is found that weak fundamental research

incomplete self-awareness

and complicated social factors are the primary causes of debates. A comprehensive analysis showed health instruments in CM have health evaluation benefits to people from a dominant Chinese culture

meet the requirements of cultural background

and bring long-term value to Chinese instrument researches. However

its values and status should be treated differently depending on various subtypes. Although little theoretical and practical evidences proved that patients-reported health instruments in CM should be proposed independently

the doctors- and nurses-reported questionnaires are necessary. With this in mind

the study group proposes the 'Chinese cultural instruments (CCIs)' and 'health-related CCIs'. The latter one aims to evaluate the health status of people in a dominant Chinese culture. The CCIs theory represents Chinese instrument researches on a larger regional and higher level

and resolves the debates on instruments between CM and Western medicine in China. Health instruments in CM bring more scientific and social benefits for Chinese instrument researches. However

it does not include cultural demands

and lacks scientific significance. CCIs have all its virtues

and add solutions to the latter's theory bottleneck and scientific debates

thus bringing increased benefits to clinical assessment in complementary and alternative medicine researches.

Abstract

Currently

there are increasing debates on the necessity of health instruments in Chinese medicine (CM) emerging in China. This study aims to reevaluate its status and values. Analyzing the causes

limits

advantages

and properties characters of health instruments in CM

it is found that weak fundamental research

incomplete self-awareness

and complicated social factors are the primary causes of debates. A comprehensive analysis showed health instruments in CM have health evaluation benefits to people from a dominant Chinese culture

meet the requirements of cultural background

and bring long-term value to Chinese instrument researches. However

the doctors- and nurses-reported questionnaires are necessary. With this in mind

and resolves the debates on instruments between CM and Western medicine in China. Health instruments in CM bring more scientific and social benefits for Chinese instrument researches. However

it does not include cultural demands

and lacks scientific significance. CCIs have all its virtues

and add solutions to the latter's theory bottleneck and scientific debates

thus bringing increased benefits to clinical assessment in complementary and alternative medicine researches.

关键词

Chinese cultureChinese Medicineinstrumentclinical outcome assessmentpatient-reported outcomevalue

Keywords

Chinese cultureChinese Medicineinstrumentclinical outcome assessmentpatient-reported outcomevalue

references

Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference, New York, 19–22 June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, No. 2, p. 100) and entered into force on 7 April 1948.

U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH). Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. (2009-12). Available at: http://www. fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryI nformation/Guidances/UCM193282.pdf

Chen KJ, Song J. Quality of life research in a period of convalescence. In: Yang WY, Wu BP, Chen SC, eds. Reviews on the new treatments for convalescence in Chinese medicine. Beijing: People's Medical Publishing House;1994:69–73.

Liu FB. Exploratory research on quality of life in patients with gastrointestinal disease. J Guangzhou Univ Tradit Chin Med (Chin) 1997;14:225–228.

Liu FB. Application and prospect of scale measurement and appraisal in the assessment in TCM therapeutic efficacy evaluation. Chin J Integr Tradit West Med (Chin) 2007;27:1129–1132.

Zhang JY, Zhou TC, Zhao FR, Qian CQ, Liu GP. Research and application of self-made scale (questionnaire) in traditional Chinese medicine. J Shanghai Univ Tradit Chin Med (Chin) 2013;27:102–105.

Chen JX. Key problems of diagnose information and syndrome questionnaire development in Chinese medicine. Chin J Basic Med Tradit Chin Med (Chin) 2011;14:1053–1054.

Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D, et al. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health 2003;6:522–531.

Liu FB, Hou ZK, Yang YY, Zhang ZZ, Xie D, Xie N, et al. Literature review and analysis of the development of health outcomes assessment instruments in CM. J Integr Med 2013;11:80–89.

Liu FB, Hou ZK, Yang YY, Li PW, Li QW, Xie N, et al. Literature review and analysis of the application of health outcome assessment instruments in CM. J Integr Med 2013;11:157–167.

Hou ZK, Liu FB, Liang YY, Zhuang KH, Lin CH, Li LJ. On the necessity of developing quality of life instruments in traditional Chinese medicine. J Integr Med (Chin) 2011;9:468–482.

Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD, et al. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA 2013;309:814–822.

Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002;11:193–205.

Zhang CL. Scientific demarcation and the survival and development of traditional Chinese medicine. Med Society (Chin) 2011;24:35–37.

WHOQOL Group. Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL). Qual Life Res 1993;2:153–159.

Rutten L, Stolper E. Complementary alternative medicine, plausibility and statistics. Eur J Intern Med 2015;26:e5.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Development is a high level inheritance for China Time-honored Brand products

Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture

Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients

Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome

Effect of Ermiao Recipe (二妙方) with medicinal guide Angelicae Pubescentis Radix on promoting the homing of bone marrow stem cells to treat cartilage damage in osteoarthritis rats